O1 Impact of intravenous belimumab treatment on steroid use and disease activity in patients with Systemic Lupus Erythematosus (SLE) in the US in clinical practice: 24-month results from the OBSErve study

• Robert Wood,
• Roger A Levy,
• Rosie Wild,
• Elke Rottier,
• Holly A Quasny,
• Marguerite Bracher,
• Seth Anderson,
• Daniel Moldaver,
• Alexandra Cusmano

Affiliations

Robert Wood

6Real-World Evidence, Adelphi Real World, Bollington, Cheshire, UK

Roger A Levy

Specialty Care, Global Medical Affairs, GSK, Collegeville, Pennsylvania, USA

Rosie Wild

6Real-World Evidence, Adelphi Real World, Bollington, Cheshire, UK

Elke Rottier

Autoimmune Franchise, Adelphi Real World, Bollington, UK

Holly A Quasny

GlaxoSmithKline, Research Triangle Park, North Carolina, USA

Marguerite Bracher

8 GSK, Stevenage, UK

Seth Anderson

3Broad Institute of MIT and Harvard, Cambridge, MA, USA

Daniel Moldaver

1Value Evidence and Outcomes, GSK, Mississauga, ON, Canada

Alexandra Cusmano

6Real-World Evidence, Adelphi Real World, Bollington, Cheshire, UK